KRAS and lung adenocarcinoma: To demonstrate the versatility and scalability of Metient, we applied it to a KRAS-mutant lung adenocarcinoma cell line with single-cell lineage tracing, a domain where migration history reconstruction was previously constrained by only simplified models of metastatic spread.